Thrivent Financial for Lutherans’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-97,716	Closed	-$5.85M	–	2508
2023 Q4	$5.85M	Buy	97,716 +18,255	+23%	+$1.09M	0.01%	799
2023 Q3	$3.02M	Buy	+79,461	New	+$3.02M	0.01%	1030